Involvement of androgen receptor and glucose-regulated protein 78kDa in human hepatocarcinogenesis

Experimental Cell Research

Volumn 323, Issue 2, 2014, Pages 326-336

  Jiang, Xia ^a   Kanda, Tatsuo ^a   Nakamoto, Shingo ^a   Miyamura, Tatsuo ^a   Wu, Shuang ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

AR; ER stress; GRP78; HCC; Sorafenib; Unfolded protein response

Indexed keywords

ANDROGEN RECEPTOR; GLUCOSE REGULATED PROTEIN 78; MESSENGER RNA; SHORT HAIRPIN RNA; SORAFENIB;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AR; ER-STRESS; GRP78; HCC; SORAFENIB; UNFOLDED PROTEIN RESPONSE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HEP G2 CELLS; HEPATOCYTES; HUMANS; NIACINAMIDE; PHENYLUREA COMPOUNDS; RECEPTORS, ANDROGEN; RNA, MESSENGER;

EID: 84897519924     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.02.017     Document Type: Article

References (47)

1. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142:1264-1273.
2. Hayashi P.H., Di Bisceglie A.M. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis. Med. Clin. North Am. 2005, 89:371-389.
3. Yoshidome H., Takeuchi D., Kimura F., Shimizu H., Ohtsuka M., Kato A., Furukawa K., Yoshitomi H., Miyazaki M. Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience. J. Am. Coll. Surg. 2011, 212:796-803.
4. Miyazaki M., Kimura F., Shimizu H., Yoshidome H., Ohtsuka M., Kato A., Yoshitomi H., Nozawa S., Furukawa K., Takeuchi D., Suda K., Yoshioka I., Mitsuhashi N. Surgical treatment for liver cancer. Current issues. Dig. Surg. 2007, 24:120-125.
5. Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.F., de Oliveira A.C., Santoro A., Raoul J.L., Fomer A., Schwartz M., Porta C., Zeuzem S., Bolondi L., Greten T.F., Galle P.R., Seitz J.F., Borbath I., Haussinger D., Giannaris T., Shan M., Moscovici M., Voliotis D., Bruix J. SHARP Investigators Study Group, Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 2008, 359:378-390.
6. Yeh S.H., Chen P.J. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 2010, 78(1):S172-S179.
7. Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J. Gastroenterol. Hepatol. 2002, 17:401-405.
8. Heinlein C.A. Androgen receptor in prostate cancer. Endocrinol. Rev. 2004, 25:276-308.
9. Gelmann E.P. Molecular biology of the androgen receptor. J. Clin. Oncol. 2002, 20:3001-3015.
10. Okitsu K., Kanda T., Imazeki F., Yonemitsu Y., Ray R.B., Chang C., Yokosuka O. Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. Genes Cancer 2010, 1:859-867.
11. Nacusi L.P., Tindall D.J. Targeting 5α-reductase for prostate cancer prevention and treatment. Nat. Rev. Urol. 2013, 8:378-384.
12. Chang C.S., Kokontis J., Liao S.T. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988, 240:324-326.
13. Bolton E.C., So A.Y., Chaivorapol C., Haqq C.M., Li H., Yamamoto K.R. Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev. 2007, 21:2005-2017.
14. Yoon G., Kim J.H., Choi Y.K., Won Y.S., Lim I.K. Direct activation of TGF-beta1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice. J. Cell Biochem. 2006, 97:393-411.
15. Tan S.S., Ahmad I., Bennett H.L., Singh L., Nixon C., Seywright M., Barnetson R.J., Edwards J., Leung H.Y. GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer. J. Pathol. 2011, 223:81-87.
16. Nagasue N., Ito A., Yukaya H., Ogawa Y. Androgen receptors in hepatocellular carcinoma and surrounding parenchyma. Gastroenterology 1985, 89:643-647.
17. Chiu C.M., Yeh S.H., Chen P.J., Kuo T.J., Chang C.J., Chen P.J., Yang W.J., Chen D.S. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2571-2578.
18. Kanda T., Steele R., Ray R., Ray R.B. Hepatitis C virus core protein augments androgen receptor-mediated signaling. J. Virol 2008, 82:11066-11072.
19. Shuda M., Kondoh N., Imazeki N., Tanaka K., Okada T., Mori K., Hada A., Arai M., Wakatsuki T., Matsubara O., Yamamoto N., Yamamoto M. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J. Hepatol. 2003, 38:605-614.
20. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999, 13:1211-1233.
21. Lee A.S. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci. 2001, 26:504-510.
22. Dorner A.J., Krane M.G., Kaufman R.J. Reduction of endogenous GRP78 levels improves secretion of a heterologous protein in CHO cells. Mol. Cell. Biol. 1988, 8:4063-4070.
23. Little E., Ramakrishnan M., Roy B., Gazit G., Lee A.S. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 1994, 4:1-18.
24. Lee A.S. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 2005, 35:373-381.
25. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell. Biol. 2007, 8:519-529.
26. Lee K., Tirasophon W., Shen X., Michalak M., Prywes R., Okada T., Yoshida H., Mori K., Kaufman R.J. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 2002, 16:452-466.
27. Rzymski T., Harris A.L. The unfolded protein response and integrated stress response to anoxia. Clin. Cancer Res. 2007, 13:2537-2540.
28. Yoshida H., Matsui T., Yamamoto A., Okada T., Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001, 107:881-891.
29. Harding H.P., Zhang Y., Bertolotti A., Zeng H., Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell. 2000, 5:897-904.
30. Haze K., Yoshida H., Yanagi H., Yura T., Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell 1999, 10:3787-3799.
31. Ye J., Rawson R.B., Komuro R., Chen X., Dave U.P., Prywes R., Brown M.S., Goldstein J.L. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell 2000, 6:1355-1364.
32. Wu J., Rutkowski D.T., Dubois M., Swathirajan J., Saunders T., Wang J., Song B., Yau G.D., Kaufman R.J. ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev. Cell. 2007, 13:351-364.
33. Jiang X., Kanda T., Tanaka T., Wu S., Nakamoto S., Imazeki F., Yokosuka O. Lipopolysaccharide blocks induction of unfolded protein response in human hepatoma cell lines. Immunol. Lett. 2013, 152:8-15.
34. Ma W.L., Hsu C.L., Wu M.H., Wu C.T., Wu C.C., Lai J.J., Jou Y.S., Chen C.W., Yeh S., Chang C. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 2008, 135:947-955.
35. Litvinov I.V., Chang C., Isaacs J.T. Molecular characterization of the commonly used human androgen receptor expression vector, pSG5-AR. Prostate 2004, 58:319-324.
36. Wu S., Kanda T., Imazeki F., Nakamoto S., Tanaka T., Arai M., Roger T., Shirasawa H., Nomura F., Yokosuka O. Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression. J. Infect. Dis. 2012, 206:415-420.
37. Novoa I., Zeng H., Harding H.P., Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J. Cell. Biol. 2001, 153:1011-1022.
38. Bennett H.L., Fleming J.T., O[U+05F3]Prey J., Ryan K.M., Leung H.Y. Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells. Cell Death Dis. 2010, 1:e72.
39. Kim S.S., Cho H.J., Kang J.Y., Kang H.K., Yoo T.K. Inhibition of androgen receptor expression with small interfering RNA enhances cancer cell apoptosis by suppressing survival factors in androgen insensitive, late stage LNCaP cells. ScientificWorld J. 2013, 2013:519397.
40. Yang Y.C., Fu H.C., Hsiao B.L., Sobue G., Adachi H., Huang F.J., Hsuuw Y.D., Wei K.T., Chang C., Huang K.E., Kang H.Y. Androgen receptor inclusions acquire GRP78/BiP to ameliorate androgen-induced protein misfolding stress in embryonic stem cells. Cell Death Dis. 2013, 4:e607.
41. Yoshikawa H., Matsubara K., Qian G.S., Jackson P., Groopman J.D., Manning J.E., Harris C.C., Herman J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 2001, 28:29-35.
42. Ikeyama S., Wang X.T., Li J., Podlutsky A., Martindale J.K., Kokkonen G., van Huizen R., Gorospe M., Holbrook N.J. Expression of the pro-apoptotic gene gadd153/chop is elevated in liver with aging and sensitizes cells to oxidant injury. J. Biol. Chem. 2003, 278:16726-16731.
43. Jamora C., Dennert G., Lee A.S. Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc. Natl. Acad. Sci.U. S. A. 1996, 93:7690-7694.
44. Dong D., Ko B., Baumeister P., Swenson S., Costa F., Markland F., Stiles C., Patterson J.B., Bates S.E., Lee A.S. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res. 2005, 65:5785-5791.
45. Lim S.O., Park S.G., Yoo J.H., Park Y.M., Kim H.J., Jang K.T., Cho J.W., Yoo B.C., Jung G.H., Park C.K. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J. Gastroenterol. 2005, 11:2072-2079.
46. Hatzivassiliou G., Haling J.R., Chen H., Song K., Price S., Heald R., Hewitt J.F.M., Zak M., Peck A., Orr C., Merchant M., Hoeflich K.P., Chan J., Luoh S.M., Anderson D.J., Ludlam M.J.C., Wiesmann C., Ulsch M., Friedman L.S., Malek S., Belvin M. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature 2013, 501:232-236.
47. Johannessen C.M., Johnson L.A., Piccioni F., Townes A., Frederick D.T., Donahue M.K., Narayan R., Flaherty K.T., Wargo J.A., Root D.E., Garraway L.A. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 2013, 504:138-142.